ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for charts Registrieren Sie sich für Echtzeit-Charts, Analysetools und Preise.

TALS Talaris Therapeutics Inc

2,72
0,00 (0,00%)
Vor Marktöffnung
Zuletzt aktualisiert: 02:00:00
Verzögert um 15 Minuten
Name Symbol Markt Aktientyp
Talaris Therapeutics Inc TALS NASDAQ Common Stock
  Änderung Änderung % Aktuell Zeit
0,00 0,00% 2,72 02:00:00
Handelsbeginn Niedrig Hoch Schlusskurs Handelsende
2,72
more quote information »

Aktuelle News

Datum Zeit Quelle Überschrift
19.4.202422:05EDGAR2Form ARS - Annual Report to Security Holders
19.4.202422:04EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
19.4.202422:02EDGAR2Form DEF 14A - Other definitive proxy statements
19.3.202422:10EDGAR2Form S-8 - Securities to be offered to employees in employee..
19.3.202422:02EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
19.3.202412:09EDGAR2Form 8-K - Current report
21.11.202300:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21.11.202300:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06.11.202322:30EDGAR2Form SC 13G - Statement of acquisition of beneficial..
30.10.202321:15EDGAR2Form SC 13D/A - General statement of acquisition of..
27.10.202323:17EDGAR2Form 8-K - Current report
27.10.202322:02EDGAR2Form SC 13G - Statement of acquisition of beneficial..
26.10.202323:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26.10.202323:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26.10.202322:46EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21.10.202303:23EDGAR2Form S-8 - Securities to be offered to employees in employee..
17.10.202323:47GLOBETalaris Therapeutics Announces Stockholder Approval of..
10.10.202322:32EDGAR2Form 425 - Prospectuses and communications, business..
10.10.202322:30EDGAR2Form 8-K/A - Current report: [Amend]
07.10.202302:01DJNStocks to Watch: Shift Technologies, Talaris Therapeutics,..
06.10.202323:30EDGAR2Form 8-K - Current report
06.10.202323:27EDGAR2Form 425 - Prospectuses and communications, business..
06.10.202323:26EDGAR2Form 8-K - Current report
06.10.202323:09GLOBETalaris Therapeutics Declares Special Dividend In Connection..
04.10.202314:30GLOBENew York Blood Center Enterprises Acquires Commercial-Scale..
26.9.202314:24EDGAR2Form 425 - Prospectuses and communications, business..
26.9.202314:21EDGAR2Form 8-K - Current report
15.9.202312:31EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
13.9.202322:28EDGAR2Form S-4/A - Registration of securities, business..
13.9.202315:14EDGAR2Form 425 - Prospectuses and communications, business..
13.9.202315:13EDGAR2Form 8-K - Current report
11.9.202322:47EDGAR2Form S-4/A - Registration of securities, business..
28.8.202313:38EDGAR2Form 425 - Prospectuses and communications, business..
25.8.202322:34EDGAR2Form S-4/A - Registration of securities, business..
14.8.202313:53EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
22.6.202313:30GLOBETalaris Therapeutics and Tourmaline Bio Announce Merger..
26.5.202313:00GLOBETalaris Therapeutics Announces Leadership Transition

Kürzlich von Ihnen besucht

Delayed Upgrade Clock